Skip to main content
. 2020 Feb 4;245(5):437–447. doi: 10.1177/1535370220903270

Figure 2.

Figure 2.

Road-map for biomarker discovery and validation. The pipeline for biomarker discovery and validation taking a hypothesis-driven approach (left) or “omics” approach (right). Meta-analysis of candidates emerging from these two approaches leads to the selection of the most promising candidates for validation studies. Candidates that pass this final validation step can then be introduced to the clinic. (A color version of this figure is available in the online journal.)